Chang Glenn 4
4 · iBio, Inc. · Filed Dec 13, 2021
Insider Transaction Report
Form 4
iBio, Inc.IBIO
Chang Glenn
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-09+109,000→ 109,000 totalExercise: $0.69From: 2022-01-09Exp: 2031-12-08→ Common Stock (109,000 underlying)
Footnotes (1)
- [F1]These options vest pro rata on a monthly basis over 12 months.